mitogen-activated protein kinase/ phosphatidylinositol 3-kinase/ mammalian target of rapamycin inhibitor (Lympharma)

N/A

Report date: 2026/03/04 16:35:25
NME

Base Information

Drug Namemitogen-activated protein kinase/ phosphatidylinositol 3-kinase/ mammalian target of rapamycin inhibitor (Lympharma)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionMitogen-activated protein kinase modulatorsPI3-kinase class I modulators
TargetsMitogen-activated protein kinasePI3-kinase class I
Therapy Area/IndicationsPrimary Myelofibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLympharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesLympharma LLC
Inactive CompaniesN/A
Active IndicationsPrimary Myelofibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A